Screener
Eligibility screening
Randomized Double-Blind Placebo-Controlled Trial Evaluating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
16 US sites in AZ, CA, CO, CT +10
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.